Safety and efficacy of celiprolol in patients with chronic obstructive lung disease;Seguridad y eficacia de celiprolol en hipertensos con enfermedad pulmonar obstructiva crónica

Revista Medica de Chile

Volumn 128, Issue 1, 2000, Pages 59-63

  Chahuán Y, Marco ^a,b   Corradi H, Luis ^a   Román A, Oscar ^a   Bravo G, Cecilia ^a  

^a HOSPITAL SAN BORJA ARRIARÁN   (Chile)

^b NONE   (Chile)

Author keywords

Adrenergic beta antagonists; Celiprolol; Lung diseases, obstructive

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELIPROLOL;

AGED; ARTICLE; BLOOD PRESSURE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; LUNG; MALE; MIDDLE AGED; SPIROMETRY;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CASE-CONTROL STUDIES; CELIPROLOL; FEMALE; HUMANS; HYPERTENSION; LUNG; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; SPIROMETRY;

EID: 0033642081     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. OPIE IH, SONNENBLICK EH, KAPLAN NM, THADANI U. Beta blocking agents. In Drugs for the Heart. Orlando. Grune & Stratton, 1987; 1-18.
2. BEUMER HM. Adverse effects of beta adrenergic receptors blocking drugs on respiratory function. Drugs 1974; 7: 130-8.
3. DOSHAN HD, ROSENTHAL RR, BROWN R, SLUTAKY A, APPLIN W, CARUSO FS. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients. J Cardiovasc Pharmacol 1986; 8 (Suppl 4): S105-S108.
4. POSTMA DS, KERSTZENS HAM. Characteristics of airways hyperesponsiveness in asthma and chronic obstructive disease. Am J Respir Crit Care Med 1998; 158: S187-S192.
5. ELLIS ME, SAHAY JN, CHATTERJEE SS, CRUISHANK JM, ELLIS SH. Cardioselectivity of atenolol in asthmatic patients. J Clin Pharmacol 1981; 21: 173-6.
6. SILKE B, ROSENTHAL F, TAYLOR S. A randomised double blind study of atenolol and celiprolol in mild to moderate hypertension. J Cardiovasc Pharmacol 1986; 8 (Suppl 4): S122-S126.
7. KAPLAN NM. Clinical Hypertension. Baltimore, Williams & Wilkins, 1994, 6th Ed.
8. MCAREAVEY D, VERMEULEN R, OBERTSON JIS. Newer beta blockers an the treatment of hypertension. Cardiovasc Drugs Ther 1991; 5: 577-88.
9. LANCASTER SG, SORKIN EM. Bisoprolol: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris. Drugs 1988; 36: 256-85.
10. GORDON RJ, PRUSS TP. Further studies in the bronchodilator properties of celiprolol hydrocholide, a cardioselective beta-blocker. Pharmacologist 1983; 29: 121-5.
11. PITTNER M. Does the B1 adrenoceptor blocking agent celiprolol have alfa 2 adrenoceptor blocking properties? Arch Intern Pharmacodyn 1987; 285: 199-210.
12. SCHINDL R, WURTH J, HOFFMAN H. The effect of the cardioselective beta blocker celiprolol on pulmonary function in asthmatic patients. J Cardiovasc Pharmacol 1986; 8 (Suppl 4): S99-S100.
13. DOSHAN HD, BROWN R, APPLIN WJ, KAPOOR M, CARUSO FS. Effects of high doses of celiprolol in asthmatic patients. J Cardiovasc Pharmacol 1986; 8 (Suppl 4): S109-S111.
14. TURNER GG, NELSON RR, NORDSTROM LA. Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris. Br Heart J 1978; 40: 1361-70.
15. CARUSO FS, DOSHAN HD, HERNÁNDEZ PH. Celiprolol pharmacokinetics and duration of pharmacodynamic activity. Br J Clin Pract 1985; Suppl 40: 12-6.
16. JOINT NATIONAL COMMITTEE ON DETECTION, EVALUATION AND TREATMENT OF HIGH BLOOD PRESSURE. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1993; 153: 154-83.
17. JOINT NATIONAL COMMITTEE ON PREVENTION, DETECTION, EVALUATION AND TREATMENT OF HIGH BLOOD PRESSURE. The sixth report. NIH publication No 98-4080, 1997.
18. GONZÁLEZ P. Consenso Nacional en Enfermedad Pulmonar Obstructiva Crónica. Rev Ch Enf Resp 1998; 14: 77-82.
19. CRAPO PD, MORRIS AH, GARDNER RM. Reference spirometric values using techniques and equipment that meet ATS recomendations. Am Rev Resp Dis 1981; 123: 659-64.
20. MC NEILL RS, INRAM CG. Effect of propranolol on ventilatory function. Am J Cardiol 1966; 18: 473-5.
21. CAPONE P, MAYOL R, MATHIEU MA. A comparative study of deliprolol and chlortalidone in hypertensive patients with reversible airway obstruction. Br J Clin Pract 1985; 39 (Suppl 6): 37-40.
22. GORDON RJ, GUNDEL R, WOLFF PS, PRUSS TP, LIEBOWITZ M. Bronchodilator properties of celiprolol hydrochloride, a cardioselective beta adrenoceptor antagonist. Fed Proc 1982; 41: 1725-9.
23. PATAKAS D, ARGIROPOULO V, LOURIDAS G, TESARA V. Beta-blockers in bronchial asthma: effect of propranolol and pindolol on large and small airways. Thorax 1983; 38: 108-12.